Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $3,664.0M | $4,706.0M | $6,043.0M | $5,595.0M | $6,101.0M | $7,521.0M | $8,053.0M | $9,983.0M | $6,297.0M | $2,556.0M | $1,233.0M | $2,825.0M | $3,499.0M | $3,001.0M | $2,155.0M | $1,335.0M | $3,196.0M | $112.0M | $3,288.0M | $5,955.0M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, AstraZeneca PLC's last 12-month Net Income is $6,495.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, AstraZeneca PLC's Net Income growth was 10.2%. The average annual Net Income growth rates for AstraZeneca PLC have been 17.8% over the past three years, 25.9% over the past five years.
Over the last year, AstraZeneca PLC's Net Income growth was 10.2%, which is higher than industry growth of (0.3%). It indicates that AstraZeneca PLC's Net Income growth is Good.